Open AccessThrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐ trans retinoic acid and arsenic trioxide
Author(s) -
Habibi Maryam,
Manouchehri Ardekani Reza,
Motedayyen Hossein
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3978
Subject(s) - arsenic trioxide , acute promyelocytic leukemia , thrombocytosis , medicine , retinoic acid , tretinoin , cancer research , leukemia , arsenic , gastroenterology , platelet , biochemistry , chemistry , organic chemistry , gene
Thrombocytosis is an unusual side effect of all‐ trans retinoic acid (ATRA) treatment that occurs in some patients with acute promyelocytic leukemia (APL).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom